45 studies found for:    stroke AND san diego | Open Studies
Show Display Options
Rank Status Study
1 Recruiting The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
Condition: Stroke, Acute
Interventions: Device: hypothermia;   Other: Group1: IV t-PA and normothermia
2 Recruiting A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke
Condition: Ischemic Stroke
Intervention: Biological: Allogeneic adult mesenchymal bone marrow stem cells
3 Recruiting The Maintenance of Human Atrial Fibrillation
Conditions: Atrial Fibrillation;   Arrhythmias, Cardiac
Intervention:
4 Recruiting Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
Condition: Acute Ischemic Stroke
Interventions: Biological: BG00002;   Drug: Placebo
5 Recruiting Hypothermia in Acute Stroke With Thrombolysis Imaging Evaluation of Revascularization
Condition: Acute Ischemic Stroke
Interventions: Other: IV t-PA and normothermia;   Device: IV-tPA and hypothermia
6 Recruiting Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel
Condition: Acute Coronary Syndrome
Interventions: Drug: Modification of Prasugrel based on a biological assay;   Drug: prasugrel / clopidogrel;   Device: Verify Now
7 Recruiting Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Condition: Atherosclerosis
Interventions: Drug: Canakinumab;   Drug: Placebo
8 Recruiting Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Exenatide Once Weekly;   Drug: Placebo
9 Recruiting ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab SAR236553 (REGN727)
Condition: Acute Coronary Syndrome
Interventions: Drug: alirocumab SAR236553 (REGN727);   Other: placebo
10 Recruiting Study of Late-Occurring Complications in Childhood Cancer Survivors
Conditions: Cancer Survivor;   Cardiovascular Complications;   Hematopoietic/Lymphoid Cancer;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Other: questionnaire administration;   Other: laboratory biomarker analysis
11 Recruiting GLORIA-AF Registry Program - Second and Third Phases
Conditions: Stroke;   Atrial Fibrillation
Intervention:
12 Recruiting Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events
Conditions: Diabetes Mellitus, Non-Insulin-Dependent;   High Risk for Cardiovascular Event
Interventions: Drug: Dapagliflozin 10 mg;   Drug: Placebo tablet
13 Recruiting A Clinical Trial to Evaluate the HeartWare® Ventricular Assist System (ENDURANCE SUPPLEMENTAL TRIAL)
Condition: Chronic Heart Failure
Interventions: Device: HeartWare® VAS;   Device: Control LVAD
14 Recruiting Cardiovascular Inflammation Reduction Trial
Condition: Cardiovascular Disease
Interventions: Drug: Methotrexate;   Drug: Placebo
15 Recruiting A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Ticagrelor 90 mg;   Drug: Ticagrelor placebo
16 Recruiting Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Condition: Arthritis, Rheumatoid
Interventions: Drug: celecoxib;   Drug: Ibuprofen;   Drug: Naproxen
17 Recruiting Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Condition: Dyslipidemia
Interventions: Biological: Evolocumab (AMG 145);   Other: Placebo;   Drug: Effective statin therapy
18 Recruiting The Evaluation Of PF-04950615 (RN316), In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects
Condition: Cardiovascular Disease
Interventions: Drug: PF-04950615;   Drug: Placebo
19 Recruiting CARMELINA: Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus at High Vascular Risk
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo;   Drug: Linagliptin
20 Recruiting Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Comorbidities
Condition: Cardiovascular Disease
Interventions: Drug: Febuxostat;   Drug: Allopurinol

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years